Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous glargine plus parenteral regular insulin versus parenteral regular insulin alone during total parenteral nutrition in hospitalized adults with diabetes
2015-003954-42Phase 4Completed
- Sponsor
- Andalusian Progress and Health Public Foundation
- Start
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Regular insulin in PN plus subcutaneous insulin glargine with Regular insulin in PN alone (2 arms). Primary endpoint: Parameters of glycemic control during total parenteral nutrition. Started Oct 2015; status: completed.
02
Drugs
insulin glarginehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-003954-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003954-42.